We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Nova Biomedical

Nova is a world leader in the development and manufacturing of whole blood, point-of-care and critical care analyzers... read more Featured Products: More products

Download Mobile App

Nova Biomedical Exhibits IVD Testing Solutions for POC and Critical Care at MEDICA 2022

By LabMedica International staff writers
Posted on 13 Nov 2022
Print article
Image: EMS Stat is a portable system for use in the emergency department to determine GLU, KET, LAC, Hb and HCT (Photo courtesy of Nova)
Image: EMS Stat is a portable system for use in the emergency department to determine GLU, KET, LAC, Hb and HCT (Photo courtesy of Nova)

Nova Biomedical (Waltham, MA, USA) is exhibiting its IVD testing solutions for point-of-care (POC) and critical care in the hospital and clinical areas at MEDICA 2022. MEDICA provides the medical device industry with a central market for innovative products and systems that result in an important contribution to the efficiency and quality of patient care.

On display at Nova’s booth is Allegro, a fast and compact POC capillary blood analyzer that offers a clinically important menu of 12 measured and individually selectable tests, as well as six calculated tests. All tests are measured with ready-to-use disposable cassettes or test strips and can be easily performed by non-technical personnel. Allegro uses a very small capillary blood drop for all blood tests, eliminating the need for venipuncture or a trained phlebotomist. With cartridge test times of six to nine minutes and the ability to measure two cartridges simultaneously, Allegro delivers fast results. Results are available during the patient visit - not after - making the patient-physician conversation more effective, reducing calls, letters and follow-up visits, and improving patient adherence to care recommendations.

Nova is also demonstrating EMS Stat, a portable system for use in the emergency department to determine GLU, KET, LAC, Hb and HCT. Stat EMS measures glucose, ketone bodies, lactate, hematocrit and hemoglobin from a capillary blood drop. Results are available within seconds, depending on the test. Combining disposable biosensor technology with portable electronics, Stat EMS provides simple, fast and accurate testing in the field. Stat EMS provides an important test menu for immediate patient assessment and faster, more effective emergency treatment. Stat EMS also assists in rapid triage and determining appropriate transport location for patients with trauma, sepsis or other special needs.

In addition, Nova is presenting the StatStrip Hemoglobin and Hematocrit Measurement System (StatStrip Hb/Hct), the only POC system that provides anemia screening and monitoring with measured rather than calculated Hb and Hct values. This important breakthrough is possible thanks to new, patented electrochemical technologies developed by Nova. Together with tiny capillary samples (1.6 µl) and results in 40 seconds, the StatStrip Hb/Hct improves clinical decision making at the POC. At MEDICA 2022, Nova is also showcasing BioProfile FLEX2 that combines Nova's breakthrough MicroSensor Card technology with optical sensing and freezing point osmometry to create an automated and comprehensive cell culture analyzer that eliminates chemical sensor maintenance, increases analyzer speed and reduces sample volume.

Related Links:
Nova Biomedical 

Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Magnetic Bead Separation Modules

Print article


Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Protein ‘signatures’ obtained via a blood sample can be used to predict the onset of 67 diseases (Photo courtesy of Queen Mary University of London)

Protein Signatures in Blood Can Predict Risk of Developing More Than 60 Diseases

Measuring specific proteins to diagnose conditions like heart attacks, where troponin is tested, is a well-established clinical practice. Now, new research highlights the broader potential of protein measurements... Read more


view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more


view channel
Image: The Simplexa C. auris direct kit is a real-time polymerase chain reaction assay run on the LIAISON MDX instrument (Photo courtesy of Diasorin)

Novel Molecular Test to Help Prevent and Control Multi Drug-Resistant Fungal Pathogen in Healthcare Settings

Candida auris (C. auris) is a rapidly emerging multi drug-resistant fungal pathogen that is commonly found in healthcare environments, where it presents a challenge due to its ability to asymptomatically... Read more


view channel
Image: The tool can improve precision oncology by accurately predicting molecular subtypes and therapy responses (Photo courtesy of Shutterstock)

Computational Tool Integrates Transcriptomic Data for Improved Breast Cancer Diagnosis and Treatment

Breast cancer is the most commonly diagnosed cancer globally, presenting in various subtypes that require precise identification for effective, personalized treatment. Traditionally, cancer subtyping has... Read more


view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.